Combination of DCA and metformin synergistically enhances cancer cell death.
HIF-1α mediates resistance to DCA/metformin induced cell death.
Glycolytic enzymes are involved in HIF-1α induced DCA/metformin resistance.
Targeting of HIF-1α may be an prerequisite for cancer metabolism targeted therapy.